Recent Finacing
Recent Raise
Enopace Biomedical develops a minimally invasive, implantable endovascular micro-stimulator and neuromodulation system to reduce left ventricular workload and improve cardiac efficiency in heart failure patients, including non‑CRT candidates.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor